Business

Mass. Movers

The numbers are looking good for NxStage

A NxStage home hemodialysis machine.

Globe file photo

A NxStage home hemodialysis machine.

Lawrence’s NxStage Medical Inc. jumped after the dialysis products manufacturer’s preliminary fourth-quarter sales numbers beat its own and analysts’ expectations. NxStage said it expects revenue of about $69 million, above its earlier guidance of between $67 and $68.5 million. The Street estimated $67.8 million. “ . . . we continue to target 15 percent annual revenue growth in the home in 2014,” CEO Jeffrey Burbank said in a statement. For the full year 2013, NxStage expects revenue of $263 million, above estimates.

Loading comments...
Real journalists. Real journalism. Subscribe to The Boston Globe today.
We hope you've enjoyed your free articles.
Continue reading by subscribing to Globe.com for just 99¢.
 Already a member? Log in Home
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com